Research Article

Aging Increases Susceptibility to High Fat Diet-Induced Metabolic Syndrome in C57BL/6 Mice: Improvement in Glycemic and Lipid Profile after Antioxidant Therapy

Table 2

Systemic glycemic and liver function markers from young and old C57BL/6 mice after pharmacological intervention with tempol (50 mg⋅kg−1) and apocynin (50 mg⋅kg−1).

ParametersYoung miceOld mice
CT-YHF-YHFT-YHFA-YCT-OHF-OHFT-OHFA-O

Insulin (ng⋅mL−1)0.66 ± 0.210.56 ± 0.060.34 ± 0.040.37 ± 0.020.44 ± 0.060.59 ± 0.020.57 ± 0.070.55 ± 0.04
Insulin resistance (TyG index)8.77 ± 0.109.11 ± 0.299.29 ± 0.109.57 ± 0.228.81 ± 0.1810.0 ± 0.139.43 ± 0.159.51 ± 0.10
HOMA index4.80 ± 1.713.32 ± 0.483.34 ± 0.533.42 ± 0.452.86 ± 0.516.56 ± 0.585.76 ± 0.695.59 ± 0.63
AST (U⋅L−1)44.30 ± 7.2765.14 ± 3.1442.54 ± 6.0659.86 ± 5.6315.80 ± 2.8732.69 ± 3.8644.25 ± 3.1142.16 ± 9.3
ALT (U⋅L−1)9.56 ± 1.2724.89 ± 0.7210.10 ± 1.1716.64 ± 5.076.11 ± 0.7217.51 ± 2.1312.26 ± 4.0617.92 ± 5.52
ALP (U⋅L−1)3195 ± 17.613246 ± 68.513212 ± 55.593285 ± 50.973114 ± 36.283076 ± 24.973232 ± 80.173245 ± 74.60
γ−GT (U⋅L−1)828.2 ± 32.80977.8 ± 100.8916.7 ± 31.911014 ± 66.68756.7 ± 6.69781.8 ± 16.85891.0 ± 56.35923.8 ± 58.82
LDH (U⋅L−1)535.8 ± 21.36593.2 ± 32.11545.4 ± 5.63643.6 ± 54.86528.0 ± 6.5521.9 ± 8.89589.2 ± 25.28562.8 ± 21.06
Albumin (mg⋅mL−1)78.51 ± 0.6678.48 ± 0.5780.20 ± 1.0578.59 ± 0.6477.64 ± 0.8077.69 ± 1.478.79 ± 0.978.69 ± 0.36
Total proteins (mg⋅mL−1)5.125 ± 0.648.373 ± 1.638.502 ± 1.016.411 ± 1.114.687 ± 1.175.855 ± 1.188.910 ± 2.910.58 ± 1.38

Y = young; O = old; CT = control group; HF = high fat diet group; HFT = high fat diet + tempol group; HFA = high fat diet + apocynin group. Values represent the mean ± SEM. ANOVA (one-way) with Bonferroni’s post hoc test: , HF versus CT; , HFT versus HF; , HFA versus HF. . TyG: insulin resistance index; HOMA index: homeostasis model assessment; AST: aspartate aminotransferase; ALT: alanine aminotransferase; ALP: alkaline phosphatase; γ-GT: gamma glutamyltransferase; LDH: lactate dehydrogenase.